ARTIE NELSON: Open Payments
NPI 1972660827 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 27 payments from 7 companies in 2025. Trend: 2023 $4,505 · 2024 $2,266 · 2025 $1,544
Food & beverage: $1,544
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $386 |
| Tris Pharma Inc | 4 | $329 |
| ABBVIE INC. | 10 | $233 |
| Axsome Therapeutics, Inc. | 2 | $223 |
| Alkermes, Inc. | 2 | $196 |
| Neurocrine BioSciences, Inc. | 1 | $122 |
| Collegium Pharmaceutical, Inc. | 3 | $54 |
Products named: REXULTI, VRAYLAR, Auvelity, Onyda XR, LYBALVI, INGREZZA, ABILIFY MAINTENA, Dyanavel XR.
Industry payments across AL — which companies pay providers there.
